AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Create a link to this page

Copy and paste this link tag into your Web page or blog:

<a href="http://www.accessmylibrary.com/coms2/summary_0286-8510598_ITM" title="Facts and information about FDA allows cancer drug developed in Cuba.">FDA allows cancer drug developed in Cuba.</a>

Close Set up an RSS feed that alerts you when new articles from CubaNews are available.

Frequently asked questions about RSS feeds

FDA allows cancer drug developed in Cuba.

CubaNews

| March 01, 2005 | COPYRIGHT 2008 Luxner News, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

The U.S. Food and Drug Administration has approved the use of YM BioSciences Inc.'s experimental TheraCIM (R3h) drug in a clinician-sponsored study to treat a child with advanced brain cancer, Toronto's Globe & Mail reported Mar. 17.

The drug earlier achieved a 35% response rate in the second of three clinical trials conducted in Germany, allowing YM's European partner to proceed to pivotal testing.

TheraCIM was developed in Cuba and has been precluded from clinical testing in the United States because of the embargo.

"This is a material step forward in potentially penetrating the U.S. …

View articles courtesy of your local library

Related articles from newspapers, magazines, journals, and more


on YM BioSciences Inc.: Press release article from: M2 Presswire September 25, 2006 700+ words
...American exchanges offer. YM BioSciences Inc. (AMEX:YMI...license that allows YM BioSciences' wholly-owned U...nimotuzumab into the United States for the purpose of...the OFAC license, YM ...


YM Biosciences completes acquisition of Eximias.: Press release article from: PR Newswire May 9, 2006 700+ words
...PRNewswire-FirstCall/ -- YM BioSciences Inc. today announced...subsidiary of YM named YM BioSciences USA and will serve...of operations in the United States. Ms. Gail Schulze...become President of YM ...


YM BioSciences to acquire Eximias Pharmaceutical Corporation.: Press release article from: PR Newswire April 13, 2006 700+ words
...operating as YM BioSciences USA Inc. and...operations in the United States. Eximias employs...registered under the United States Securities Act...sold in the United States absent ...


Update - YM BioSciences to acquire Eximias Pharmaceutical Corporation.: Press release article from: PR Newswire April 17, 2006 700+ words
...YM operating as YM BioSciences USA Inc. and...operations in the United States. In order to...compliance with United States securities laws...Chairman and CEO of YM BioSciences and several ...


YM BioSciences raises US $ 40 million.: Press release article from: PR Newswire February 14, 2006 700+ words
...addition to tesmilifene, YM BioSciences is developing nimotuzumab...including cancer pain. YM BioSciences is also developing...requirements of the United States Securities Act of 1933...Carolyn McEwen, YM ...


YM BioSciences' TheraCIM receives IND.: Press release article from: PR Newswire UK Disclose March 16, 2005 700+ words
YM BioSciences' TheraCIM receives investigator...March 16 /CNW/ - YM BioSciences Inc. (AMEX:YMI...Chairman and CEO of YM BioSciences. "The clinical success...pediatric patients in the United ...


YM BioSciences Expands Development Program for Lead Cancer Drug; - YM Partners...: Press release article from: PR Newswire January 31, 2005 700+ words
...Chairman and CEO of YM BioSciences. "Shin Poong management...Corporate Development for YM BioSciences. "Because Korean...diagnosed annually in the United States and more than 50...malarial drug. About YM ...


YM BioSciences reports successful regulatory reviews of nimotuzumab...: Press release article from: PR Newswire May 24, 2007 700+ words
...PRNewswire-FirstCall/ -- YM BioSciences Inc. , an oncology...Chairman and CEO of YM BioSciences. About Nimotuzumab...same indication in the United States and Canada and also...nimotuzumab. About YM ...


YM Biosciences Reports Second Quarter 2007 Operational and Financial Results.: Press release article from: PR Newswire February 9, 2007 700+ words
...Chairman and CEO of YM BioSciences. "However, this...programs and partners. YM BioSciences is exiting our fiscal...Oncoscience AG in Germany. YM BioSciences is in the planning...same indication in the United ...


YM BioSciences reports third quarter 2007 operational and financial results.: Press release article from: PR Newswire May 11, 2007 700+ words
...PRNewswire-FirstCall/ -- YM BioSciences Inc. , an oncology company...Allan, Chairman and CEO of YM BioSciences. "We maintain a solid financial...in the same indication in the United States and Canada. - YM anticipates...

For more facts and information, see all results

Source: HighBeam Research, FDA allows cancer drug developed in Cuba.

The AccessMyLibrary advertising network includes: